EquityZen Growth Technology Fund LLC - Series 1044
Raised
$646K
Investors
34
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1044 is a Delaware-domiciled pooled investment fund filed December 2021 by EquityZen Advisors LLC and related parties. The fund raised $646K from 34 investors with a $10K minimum investment, claiming exemptions under Rule 506(b) and Section 3(c)(1). It is part of the EquityZen platform, which operates nearly 1,900 related EDGAR entities focused on pre-IPO secondary market investments.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption combination typical of private fund offerings, with a $10K minimum that positions it in the accessible retail-accredited tier. The 34-investor count and $646K raise reflect a highly granular capital structure common to EquityZen's SPV model for fractionalizing access to late-stage private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
